The Quantellect read.As of Nov 19, 2026, 3 active firms cover Pmv Pharmaceuticals Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $3.00 to $5.00, a moderate spread. The average target of $4.33 sits 254% above the current $1.23. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.27 next quarter toward $-0.94 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$4.33
+253.7% upside
Average target across 3 active firms as of Nov 19, 2026 vs $1.23 current
Highest Target$5.00
Average Target$4.33
Lowest Target$3.00
Detailed analyst forecasts for PMVP
Showing 1–2 of 2 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate PMVP a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PMVP EPS & revenue forecast
EPS · NEXT QUARTER
$-0.27
Range $-0.35 – $-0.17 · 3 analysts · -20% YoY
Next period, 3 analysts expect Pmv Pharmaceuticals Inc to earn $-0.27 a share (range $-0.35 – $-0.17), versus $-0.34 a year earlier. Full-year consensus is $-1.29, growing to $-0.94 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 3 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $6.5M next year.
Top analysts covering Pmv Pharmaceuticals Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PMVP.
#1
RB
Robert Burns
HC Wainwright & Co. · Rank #215
Buy
$5.00+308.2% to target
Overall win rate
42%
+ Follow
#2
Jeff Jones
Oppenheimer · Rank #320
Buy
$5.00+308.2% to target
Overall win rate
32%
+ Follow
#3
Yaron Werber
TD Cowen
Buy
No targeton PMVP
Coverage
—
+ Follow
#4
AL
Albert Lowe
Craig-Hallum
Buy
$4.00+226.5% to target
Coverage
—
+ Follow
PMVP stock forecast FAQ
What is PMVP's average 12-month price target?+
The 3 active firms with a live target average $4.33 for Pmv Pharmaceuticals Inc over the next 12 months, ranging from a $5.00 high to a $3.00 low, as of Nov 19, 2026.
Is PMVP stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for PMVP?+
The Street-high target is $5.00 (HC Wainwright & Co.), and the Street-low is $3.00. The average of all 3 active-firm targets is $4.33.
How many active Wall Street firms cover PMVP?+
3 active firms have a recognized rating on Pmv Pharmaceuticals Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PMVP?+
Among analysts who currently cover PMVP, Robert Burns of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #215). Their current call is Buy with a $5.00 target.
What is Pmv Pharmaceuticals Inc's projected EPS for next quarter?+
The consensus estimate is $-0.27 per share (range $-0.35 – $-0.17) across 3 analysts. Full-year EPS is projected at $-1.29, rising to $-0.94 the following year.
How much revenue is Pmv Pharmaceuticals Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $6.5M next year.
Have analysts been upgrading or downgrading PMVP lately?+
As of Nov 19, 2026, 3 of 3 active firms rate PMVP a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PMVP calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.